Jpmorgan Chase & CO Nkarta, Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Nkarta, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 302,013 shares of NKTX stock, worth $975,501. This represents 0.0% of its overall portfolio holdings.

Number of Shares

302,013

Previous 345,159 12.5%

Holding current value

$975,501

Previous $3.73 Million 52.18%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$5.27 - $10.82 $227,379 - $466,839	-43,146 Reduced 12.5%	302,013 $1.78 Million
Q1 2024 May 10, 2024	SELL	$5.59 - $15.71 $67,381 - $189,368	-12,054 Reduced 3.37%	345,159 $3.73 Million
Q4 2023 Feb 12, 2024	SELL	$1.31 - $6.6 $12,266 - $61,802	-9,364 Reduced 2.55%	357,213 $2.36 Million
Q3 2023 Nov 14, 2023	SELL	$1.39 - $2.29 $22,050 - $36,328	-15,864 Reduced 4.15%	366,577 $509,000
Q2 2023 Aug 11, 2023	SELL	$2.19 - $5.17 $15,148 - $35,760	-6,917 Reduced 1.78%	382,441 $837,000
Q1 2023 May 18, 2023	BUY	$3.37 - $6.3 $84,573 - $158,104	25,096 Added 6.89%	389,358 $1.38 Million
Q1 2023 May 11, 2023	SELL	$3.37 - $6.3 $68,346 - $127,770	-20,281 Reduced 5.27%	364,262 $1.29 Million
Q4 2022 Feb 13, 2023	SELL	$5.14 - $14.35 $7,560 - $21,108	-1,471 Reduced 0.38%	384,543 $2.3 Million
Q3 2022 Nov 14, 2022	BUY	$12.27 - $18.39 $1.14 Million - $1.71 Million	93,076 Added 31.77%	386,014 $5.08 Million
Q2 2022 Aug 11, 2022	BUY	$7.77 - $19.44 $177,264 - $443,504	22,814 Added 8.45%	292,938 $3.61 Million
Q1 2022 May 11, 2022	SELL	$8.66 - $14.99 $44,512 - $77,048	-5,140 Reduced 1.87%	270,124 $3.07 Million
Q4 2021 Feb 10, 2022	SELL	$12.79 - $26.88 $296,050 - $622,191	-23,147 Reduced 7.76%	275,264 $4.23 Million
Q3 2021 Nov 12, 2021	BUY	$26.67 - $38.76 $7.96 Million - $11.6 Million	298,411 New	298,411 $8.3 Million

Others Institutions Holding NKTX

# of Institutions

124

Shares Held

66.2M

Call Options Held

142K

Put Options Held

43.1K

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $157M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Nkarta, Inc. Transaction History